BlossomHill Therapeutics

San Diego, CA · Founded 2020 · Privately Held (backing)

Operator of a biopharmaceutical company designed to develop treatments for oncology and autoimmune diseases. BlossomHill Therapeutics is based in San Diego, CA and was founded in 2020. It was valued at $413 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $257 million across 4 recorded rounds; the latest was an $84.2 million later-stage round in Nov 2025.

PMV mark · valuation
$413.1M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$257.1M
Last round
Later Stage VC
Nov 2025
How much has BlossomHill Therapeutics raised?
$257.1Macross 4 recorded rounds · Dec 2020 – Nov 2025

Most recently, BlossomHill Therapeutics raised $84.2M in its Later Stage VC (Nov 2025).

Free account
More of BlossomHill Therapeutics with a free account
  • ·Watch BlossomHill Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

BlossomHill Therapeutics round by round

4 rounds
Nov 2025Later Stage VC$84.2MSEC filing▮
47 investors participated
Dec 2023Later Stage VC$88.6MSEC filing▮
44 investors participated
Mar 2021Later Stage VC$71.0MSEC filing▮
27 investors participated
Dec 2020Seed Round$2.0MSEC filing▮
3 investors participated

How much has BlossomHill Therapeutics raised?

BlossomHill Therapeutics has raised $257 million across 4 recorded rounds since 2020. The largest was an $88.6 million later-stage round in Dec 2023; the most recent was an $84.2 million later-stage round in Nov 2025.

BlossomHill Therapeutics has filed 4 Form Ds with the SEC since 2021, most recently in Dec 2025 ($84.2 million sold to 47 investors).

BlossomHill Therapeutics investors

10 investors are on record for BlossomHill Therapeutics, including OrbiMed, Cormorant Asset Management, Vivo Capital and BioTrack Capital. The later-stage round in Nov 2025 drew 47 investors.

For fundraisers
Raising for a company like BlossomHill Therapeutics?

10 investors have backed BlossomHill Therapeutics.

See all 10 investors →

Frequently asked about BlossomHill Therapeutics

How much has BlossomHill Therapeutics raised?
BlossomHill Therapeutics has raised $257.1M in total across 4 recorded funding rounds.
When was BlossomHill Therapeutics's last funding round?
BlossomHill Therapeutics's most recent recorded round was Later Stage VC in Nov 2025, raising $84.2M.